Details of the Drug

General Information of Drug (ID: DMRWHJT)

Drug Name

IOV-2001

Indication

Disease Entry	ICD 11	Status	REF
Chronic lymphocytic leukaemia	2A82.0	Phase 1/2	[1]
Small lymphocytic lymphoma	2A82.0	Phase 1/2	[1]
------------------------------------------------------------------------------------

Drug Type

Cell therapy

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04155710) Study of Autologous Peripheral Blood Lymphocytes in the Treatment of Patients With CLL or SLL. U.S. National Institutes of Health.